tyramine has been researched along with Bladder Cancer in 3 studies
Excerpt | Relevance | Reference |
---|---|---|
"Thus, CpdA likely inhibits bladder cancer growth predominantly via inducing GR transrepression and at least partially mediated through the AR pathway, suggesting its effects more beneficial than GCs/pure GR ligands or AR antagonists." | 1.42 | Compound A Inhibits Bladder Cancer Growth Predominantly via Glucocorticoid Receptor Transrepression. ( Ide, H; Inoue, S; Ishiguro, H; Jalalizadeh, M; Kashiwagi, E; Kawahara, T; Miyamoto, H; Reis, LO; Zheng, Y, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zheng, Y | 1 |
Ishiguro, H | 1 |
Ide, H | 1 |
Inoue, S | 1 |
Kashiwagi, E | 1 |
Kawahara, T | 1 |
Jalalizadeh, M | 1 |
Reis, LO | 1 |
Miyamoto, H | 1 |
Kaufmann, O | 1 |
Baume, H | 1 |
Dietel, M | 1 |
Lachhein, L | 1 |
Schütz, J | 1 |
1 review available for tyramine and Bladder Cancer
Article | Year |
---|---|
[Possibilities and limitations in the diagnosis of pheochromocytoma].
Topics: Adrenal Gland Neoplasms; Blood Pressure; Catecholamines; Chromatography; Epinephrine; Histamine; Hum | 1969 |
2 other studies available for tyramine and Bladder Cancer
Article | Year |
---|---|
Compound A Inhibits Bladder Cancer Growth Predominantly via Glucocorticoid Receptor Transrepression.
Topics: Acetates; Androgen Antagonists; Animals; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation | 2015 |
Detection of oestrogen receptors in non-invasive and invasive transitional cell carcinomas of the urinary bladder using both conventional immunohistochemistry and the tyramide staining amplification (TSA) technique.
Topics: Adult; Aged; Aged, 80 and over; Biotin; Carcinoma, Transitional Cell; Female; Humans; Immunoenzyme T | 1998 |